NF Northeast Research Grant Program

The NF Northeast Research Funding Opportunity is offered by Neurofibromatosis Northeast to support biomedical research related to neurofibromatosis. The awards are intended as seed funding for the initiation of projects and the generation of preliminary data that may support future applications to federal, foundation, or industry funding sources. Early-career faculty are specifically encouraged to apply. Candidates with more than two years of postdoctoral experience may also be considered when their application includes confirmation from the candidate's institution or department and mentor that the institution supports the applicant and that the candidate's guaranteed funded appointment will extend through the proposed project period. Awards are available for up to $75,000 in total costs for a one-year project period running from December 4, 2026 through December 4, 2027. The total award may include no more than 10 percent indirect costs. Allowable expenses may include salary support expressed as percent effort or calendar months, research technician or coordinator support, research supplies, travel related to the project, and other justified project-related expenses. Tuition and coursework-related expenses are not allowable. Applicants must disclose all current and pending support and explain any scientific or budgetary overlap with the proposed project. NF Northeast may provide partial or supplemental funding, and preferred candidates should demonstrate sufficient existing or pending research support to successfully complete the proposed project if only partial or supplemental support is provided. No cost-share or matching contribution is stated as a requirement. Preferred candidates will demonstrate a strong record of biomedical research productivity, including peer-reviewed publications and prior funding from competitive granting agencies; a demonstrated commitment to NF research; institutional support, including agreement to accept the award with indirect costs capped at 10 percent; and sufficient existing or pending research support to complete the proposed work if NF Northeast provides partial or supplemental funding. All supported clinical research and animal research must comply with applicable institutional, local, state, and federal regulations and guidelines governing the protection of human and animal participants. Awardees may be invited to attend NF Northeast general or executive meetings to formally receive the award or discuss research progress and outcomes with NF Northeast members. A complete application must be submitted as a single PDF using a minimum 11-point Arial font and 1-inch margins. The application must contain a brief cover letter addressed to the Review Committee and a project proposal. Excluding the lay summary and references, the proposal may not exceed three pages and should include the project title; a project lay summary of no more than 100 words; background and significance; specific aims and hypotheses; preliminary data, if available; methods; an analysis plan; and a project timeline describing anticipated milestones and deliverables. References may occupy up to one additional page. Applicant materials include a curriculum vitae showing current and pending funding support, conflict-of-interest disclosure if applicable, the NF Northeast conflict-of-interest form for disclosure of potential relationships with relevant commercial entities, and a letter from the institution's Office of Grants and Contracts and mentor when applicable confirming institutional support. An NIH Biosketch may be included but does not replace the required CV. The budget is separate from the project proposal and may request up to $75,000 in total costs inclusive of the permitted indirect costs. A budget justification of no more than one page must describe and justify all requested costs. Applications are submitted by emailing the full proposal to research@nfnortheast.org. The application period opened July 1, 2026, and proposals must be received by 5:00 p.m. on October 13, 2026. Because the source gives a submission time but no time zone, the specified data-entry rule treats the time as Eastern Time while storing the deadline as the date only. No letter of intent, concept paper, pre-proposal, notice of intent, or other pre-application gating step is stated. The Medical/Scientific Committee is scheduled to review applications from October 14 through November 13, 2026. Award notifications are scheduled for November 16, 2026, and the funding period begins December 4, 2026. The source's preferred-candidate criteria indicate that biomedical research productivity, commitment to NF research, institutional support, compliance with the indirect-cost cap, and sufficient supporting research resources are material considerations in the review. Investigators must submit a final report of no more than two pages within one month after the funding period ends. The report must summarize project outcomes and key findings, provide a brief lay summary of the work's significance, account for the use of funds, and identify abstracts, manuscripts, or publications submitted or published as a result of the research. Subsequent publications arising from the funded work should also be forwarded to NF Northeast. Unless otherwise specified, abstracts, presentations, and publications resulting from NF Northeast-funded research should acknowledge support from Neurofibromatosis Northeast and identify www.nfnortheast.org. Funding through this mechanism does not imply continued or renewable support after the approved project period. Investigators seeking continued funding must submit a new application for future consideration. The source does not state that the opportunity recurs annually or on another regular schedule, so no recurring next-cycle date is assigned. Receipt of an award also does not constitute automatic endorsement by NF Northeast of an investigator, laboratory, institution, or affiliated organization in public communications or promotional materials.

Focus the proposal on biomedical research relevant to neurofibromatosis; observe the three-page project proposal maximum; ensure the budget accounts for the $75,000 ceiling inclusive of 10% indirect costs; compile all required components into a single PDF; early-career faculty are especially encouraged to apply.